Types of Non-clinical Studies

Nonclinical studies play a critical role in new drug development. These studies are conducted to assess a drug’s efficacy, safety, and behavior in the body, and to evaluate its potential before advancing to clinical trials. Below are typical types of nonclinical studies.

Pharmacology (Efficacy) Studies

Pharmacology (efficacy) studies evaluate how a drug acts against a specific disease. In particular, they examine the extent to which the intended therapeutic effect is achieved and, where applicable, the mechanism of action. Animal and cell-based models are used to determine whether the expected effect is observed. The results provide essential evidence of efficacy and form the foundational data to proceed to clinical studies.

Toxicology Studies

Safety (toxicology) studies evaluate the degree to which a drug is safe for human use. These studies identify potential adverse effects and toxicities and generate data to inform appropriate dosing. Using animal studies and other models, both short-term and long-term effects are examined. This work helps minimize risk in humans and helps ensure that clinical trials can proceed on a sound safety basis.

Pharmacokinetic Studies(PK)

Pharmacokinetic studies assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) in the body. The objective is to clarify how the drug moves through the body and what changes occur along the way. PK results are important for dose selection and dosing regimen decisions and provide core data that can help predict a drug’s safety and efficacy.

Other Studies: Toxicity and Carcinogenicity

In addition to pharmacodynamic, safety, and pharmacokinetic studies, various other tests are essential to assure the safety of new drugs and chemicals before they are used in humans. Below you will find information on toxicity and carcinogenicity testing.

Toxicity Studies

Toxicity studies evaluate the degree of toxicity a drug may exert. They determine whether the drug has harmful effects on specific organs or tissues. Typical designs include acute, subacute, and chronic toxicity studies, which assess effects after single or repeated/long-term dosing. Results establish the drug’s safety profile and support clinical trial design.

Carcinogenicity Studies

Carcinogenicity studies evaluate whether long-term use of a drug could increase the risk of cancer. These studies are typically conducted in animal models to determine whether prolonged exposure promotes tumor development in specific organs or tissues. The results provide important data for risk assessment and risk management in defined patient populations.

Summary

Nonclinical studies are an essential stage in new drug development, used to evaluate efficacy, safety, pharmacokinetics, toxicity, and carcinogenicity. Their results support benefit–risk assessment before clinical entry and provide foundational data to establish appropriate dosing and therapeutic approaches. Accurate and rigorous execution of these studies is critical to development success.